Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using CQI to prevent the placebo effect from causing failed clinical trials.

J Fawcett1, M E Sinioris

  • 1Department of Psychiatry, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA.

Quality Management in Health Care
|October 28, 1999
PubMed
Summary

The placebo effect complicates drug development. Implementing continuous quality improvement (CQI) in clinical studies, including data evaluation and rater training, enhances study validity and reliability for better drug outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective spatial analysis of cases of COVID-19 in a single military accommodation block corridor, RMAS, January-March 21.

BMJ military health·2022
Same author

Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

How can schistosome circulating antigen assays be best applied for diagnosing male genital schistosomiasis (MGS): an appraisal using exemplar MGS cases from a longitudinal cohort study among fishermen on the south shoreline of Lake Malawi.

Parasitology·2019
Same author

Recent advances in the therapeutic uses of chondroitinase ABC.

Experimental neurology·2019
Same author

Mortality from Listeria monocytogenes meningoencephalitis following escalation to alemtuzumab therapy for relapsing-remitting Multiple Sclerosis.

Multiple sclerosis and related disorders·2018
Same author

The role of macrophages in the development of biliary injury in a lipopolysaccharide-aggravated hepatic ischaemia-reperfusion model.

Biochimica et biophysica acta. Molecular basis of disease·2017

Area of Science:

  • Clinical research methodology
  • Psychopharmacology
  • Drug development

Background:

  • The human mind, specifically the placebo effect, significantly impacts patient responses in clinical trials.
  • Billions invested in research and development (R&D) are challenged by the placebo effect, complicating drug efficacy assessment.
  • Current clinical study designs often lack robust methodologies to mitigate placebo effect influence.

Purpose of the Study:

  • To propose an ongoing methodology for reducing the impact of the placebo effect in clinical trials.
  • To advocate for the integration of a continuous quality improvement (CQI) model into the initial design of clinical studies.
  • To enhance the validity and reliability of study outcomes through improved research performance.

Main Methods:

Related Experiment Videos

  • Implementing a continuous quality improvement (CQI) program.
  • Establishing continuous evaluation of study participant data.
  • Incorporating regular rater training protocols.

    • Main Results:

    • The proposed CQI model aims to systematically reduce the influence of the placebo effect.
    • Continuous data evaluation allows for timely identification and correction of performance issues.
    • Enhanced rater training ensures consistent and accurate assessment of participant responses.

    Conclusions:

    • Integrating a CQI program from the outset of clinical study design is crucial for managing the placebo effect.
    • Continuous evaluation and rater training are key components of a successful CQI strategy.
    • This approach leads to more valid studies and reliable outcomes, ultimately improving drug development efficiency.